Alset International Limited (SGX: 40V) is a Singapore-based company that has been listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (“SGX-ST”) since July 2010. The company has diversified its portfolio to include property development and related services, information technology-related businesses, development, research, testing, manufacturing, licensing, and distribution of biomedical products, as well as investment activities.
Alset International Limited is focused on pursuing corporate recovery and aims to achieve scalability, sustainability, and growth. The company leverages the expertise and experience of its management team to enhance shareholder value. The company operates primarily in the biotechnology and pharmaceutical industries.
With a strong presence in Singapore, Alset International Limited continues to expand into international markets. The company is committed to driving value for its shareholders through strategic investments and sustainable growth strategies.
There is no investment information
No recent news or press coverage available for Alset International Limited.